Xianghan Lu

825 total citations
7 papers, 493 citations indexed

About

Xianghan Lu is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Xianghan Lu has authored 7 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Xianghan Lu's work include Respiratory viral infections research (4 papers), Influenza Virus Research Studies (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Xianghan Lu is often cited by papers focused on Respiratory viral infections research (4 papers), Influenza Virus Research Studies (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Xianghan Lu collaborates with scholars based in United States, India and United Kingdom. Xianghan Lu's co-authors include Michael Citron, Xiaoping Liang, Raghavan Varadarajan, Gwendolyn J. Heidecker, Cheryl Callahan, Jan ter Meulen, Gayathri Bommakanti, Tariq Ahmad Najar, Vamsee Mallajosyula and Siddhartha P. Sarma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Xianghan Lu

7 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianghan Lu United States 6 388 161 159 114 76 7 493
Juine-Ruey Chen Taiwan 8 340 0.9× 132 0.8× 128 0.8× 222 1.9× 80 1.1× 13 523
Anouk Smet Belgium 8 472 1.2× 280 1.7× 129 0.8× 156 1.4× 189 2.5× 12 601
Julianna Han United States 11 276 0.7× 197 1.2× 126 0.8× 249 2.2× 54 0.7× 26 519
C. Gerdil France 5 420 1.1× 134 0.8× 146 0.9× 103 0.9× 41 0.5× 5 501
Christopher W. Seibert United States 9 342 0.9× 152 0.9× 110 0.7× 82 0.7× 26 0.3× 9 432
Alec W. Freyn United States 9 218 0.6× 168 1.0× 170 1.1× 192 1.7× 59 0.8× 13 475
Iuliia M. Gilchuk United States 9 312 0.8× 128 0.8× 105 0.7× 136 1.2× 117 1.5× 13 418
Kathryn A. Hooper United States 7 288 0.7× 79 0.5× 87 0.5× 180 1.6× 64 0.8× 7 453
Raphael Tze Chuen Lee Singapore 10 365 0.9× 79 0.5× 121 0.8× 149 1.3× 15 0.2× 20 472
Shin-etsu Kadowaki Japan 8 202 0.5× 165 1.0× 75 0.5× 80 0.7× 23 0.3× 10 343

Countries citing papers authored by Xianghan Lu

Since Specialization
Citations

This map shows the geographic impact of Xianghan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianghan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianghan Lu more than expected).

Fields of papers citing papers by Xianghan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianghan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianghan Lu. The network helps show where Xianghan Lu may publish in the future.

Co-authorship network of co-authors of Xianghan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xianghan Lu. A scholar is included among the top collaborators of Xianghan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianghan Lu. Xianghan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Pitts, Jared, Jiani Li, Jason K. Perry, et al.. (2022). Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants. Antimicrobial Agents and Chemotherapy. 66(6). e0022222–e0022222. 48 indexed citations
2.
Pitts, Jared, Darius Babusis, Meghan S. Vermillion, et al.. (2022). Intravenous delivery of GS-441524 is efficacious in the African green monkey model of SARS-CoV-2 infection. Antiviral Research. 203. 105329–105329. 5 indexed citations
3.
Mallajosyula, Vamsee, Michael Citron, Francesca Ferrara, et al.. (2014). Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection. Proceedings of the National Academy of Sciences. 111(25). E2514–23. 161 indexed citations
4.
Mallajosyula, Vamsee, Michael Citron, Xianghan Lu, et al.. (2013). In vitro and in vivo characterization of designed immunogens derived from the CD-helix of the stem of influenza hemagglutinin. Proteins Structure Function and Bioinformatics. 81(10). 1759–1775. 10 indexed citations
5.
Bommakanti, Gayathri, Xianghan Lu, Michael Citron, et al.. (2012). Design of Escherichia coli-Expressed Stalk Domain Immunogens of H1N1 Hemagglutinin That Protect Mice from Lethal Challenge. Journal of Virology. 86(24). 13434–13444. 71 indexed citations
6.
Bommakanti, Gayathri, Michael Citron, Robert W. Hepler, et al.. (2010). Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge. Proceedings of the National Academy of Sciences. 107(31). 13701–13706. 180 indexed citations
7.
Lu, Xianghan, Charlene Michaud, & Marian Orłowski. (2001). Heat Shock Protein-90 and the Catalytic Activities of the 20 S Proteasome (Multicatalytic Proteinase Complex). Archives of Biochemistry and Biophysics. 387(1). 163–171. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026